Top compounds associated with response to FAM168A


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA RG-108 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA 17-AAG CCLE pan-cancer AAC -0.17 0.0003
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.11 0.0006
Download CSV